Press, Articles, and Publications
T-Cell Therapy Puts Leukemia Patients in Extended Remission
An experimental therapy has brought prolonged remissions to a high proportion of patients who were facing death from advanced leukemia after standard treatments had failed, researchers are reporting.
The therapy involves genetically programming cells from the patient’s own immune system to fight the disease.
The research included 30 patients: five adults ages 26 to 60, and 25 children and young adults ages 5 to 22. All were severely ill, with acute lymphoblastic leukemia, and had relapsed several times or had never responded to typical therapies. In more than half, the disease had come back even after a stem-cell transplant, which usually gives patients the best hope of surviving. Their life expectancy was a few months, or in some cases just weeks.
Six months after being treated, 23 of the 30 patients were still alive, and 19 of them have remained in complete remission.
The study, by researchers at the Children’s Hospital of Philadelphia and the Hospital of the University of Pennsylvania, is being published in The New England Journal of Medicine….. [citing Oct 15th, 2014 NY times article by Denise Grady]
Claire S. Philipp has been named the Melvyn, Ab and Yetta Motolinsky Chair in Hematology
Reflecting the mission of the Motolinsky Foundation, Philipp’s clinical practice and research focus on hematology. An expert in bleeding and clotting disorders, she is director of the Special Hemostasis Laboratory, a statewide referral laboratory for the performance of highly specialized diagnostic testing for these disorders. Philipp also oversees the Thrombosis Center, the Women with Bleeding Disorders Program, and the New Jersey Regional Hemophilia Program at Rutgers Robert Wood Johnson Medical School, where she also is director of the Motolinsky Research Laboratory….
Jack Borrus appointed chair of the board of directors of the Robert Wood Johnson University Hospital Foundation
Congratulations is in order for the Princeton resident Jack Borrus, who has been appointed chair of the board of directors of the Robert Wood Johnson University Hospital Foundation of New Brunswick. Mr. Borrus was formerly vice chair and treasurer of the Hospital Foundation.
Mr. Borrus, treasurer of the Melvyn H Motolinsky Research Foundation, resides in Princeton with his wife, Adele, and is president of Borrus, Goldin, Foley, Vignuolo, Hyman & Stahl P.C., a 50-year-old regional law firm based in North Brunswick….
READ FULL ARTICLE
President McCormick recognized for support of biomedical research and education
President Richard L. McCormick was presented with the Melvyn H. Motolinsky Research Foundation’s 2006 Distinguished Citizen Award at the foundation’s annual meeting November 5 at UMDNJ-Robert Wood Johnson University Medical School in New Brunswick.
Dr. Clifton R. Lacy, president and CEO of Robert Wood Johnson University Hospital (RWJUH), and president of the Motolinsky Foundation, said that “Dr. McCormick was selected to receive the award because of his strong and passionate support of biomedical research and education, his dedication and involvement in projects serving the community, and his distinguished and significant service to Rutgers … as a professor and now as its president.” ….
READ FULL ARTICLE
Research foundation honors hospital CEO with distinguished service award
Stephen K. Jones, FACHE, president and CEO of Robert Wood Johnson University Hospital and Robert Wood Johnson Health System, received the Melvyn H. Motolinsky Research Foundation’s 2011 Distinguished Service Award.
For more than 35 years, the foundation has granted its annual Distinguished Service Award to honorees for outstanding service to the community. Past recipients include New Jersey Sen. Joseph Vitale, Rutgers University President Richard McCormick and Dr. Clifton Lacy, former New Jersey Commissioner of Health and Senior Services and former RWJUH president….
READ FULL ARTICLE
Child Health Researcher Recognized for Distinguished Service
New Brunswick, NJ – For more than 40 years, the Melvyn H. Motolinsky Research Foundation has supported hematology research, funding efforts to treat and cure leukemia and other blood-related diseases. Established in 1972, the Motolinsky Foundation is a living memorial to Melvyn H. Motolinsky, a young lawyer who died at age 26, only two months after he was diagnosed with leukemia.
Each year it recognizes a leader in medical service to the community and is bestowing the 2013 Distinguished Service Award upon Arnold B. Rabson, MD, director of the Child Health Institute of New Jersey and Laura Gallagher Endowed Professor of Developmental Biology, and professor of pediatrics, pharmacology, and pathology and laboratory medicine at Robert Wood Johnson Medical School, part of Rutgers, The State University of New Jersey….
READ FULL ARTICLE
World-renowned Rutgers neuroscientist Wise Young recognized
NEW BRUNSWICK/PISCATAWAY, N.J. – Dr. Wise Young, the Richard H. Shindell Professor of Neuroscience at Rutgers University and founding director of Rutgers’ W.M. Keck Center for Collaborative Neuroscience, is receiving the Melvyn H. Motolinsky Research Foundation’s 2007 Distinguished Service Award.
Dr. Clifton R. Lacy, president of the Motolinsky Foundation, associate professor of medicine at UMDNJ-Robert Wood Johnson Medical School and adjunct professor at Rutgers University Ernest Mario School of Pharmacy, said that Dr. Young was selected to receive the award because of his groundbreaking research in the treatment of spinal cord injury as well as his passionate support of stem cell research. “We also recognize the compassion and caring he shows for individuals with spinal cord injury and their families,” Lacy said….
READ FULL ARTICLE